Cargando…
Corticosteroids Replacement in a Patient With Panhypopituitarism and COVID-19 Infection
Background: Hypopituitarism refers to complete or partial insufficiency of pituitary hormone secretion and patients require lifelong hormone replacement. Those with ACTH deficiency rely on exogenous glucocorticoids and at times of intercurrent illness require stress doses to prevent an adrenal crisi...
Autores principales: | Karuppasamy, Gowri, Alamer, Zaina Abdelhalim, Rose, Samman, Al-Janahi, Ibrahim Abdulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090643/ http://dx.doi.org/10.1210/jendso/bvab048.1180 |
Ejemplares similares
-
Are High Doses of Corticosteroids Protective in COVID-19 Patient With Panhypopituitarism?
por: Kurir, Tina Ticinovic, et al.
Publicado: (2021) -
SAT624 Neurosarcoidosis Presenting With Panhypopituitarism
por: Niedzialkowska, Ewelina Marta, et al.
Publicado: (2023) -
FRI333 Neurosarcoidosis Induced Panhypopituitarism
por: Alfares, Khalid, et al.
Publicado: (2023) -
Is It the COVID-19 and Untreated Panhypopituitarism a Deadly Combination: A Case Report?
por: Burekovic, Azra, et al.
Publicado: (2021) -
ODP285 A Case of Encephalitis and Adrenal Insufficiency in a Patient With Panhypopituitarism After COVID-19 Vaccination
por: Yabe, Ichiro, et al.
Publicado: (2022)